Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Erytech Pharma ADR (NQ: ERYP )

N/A UNCHANGED
Last Price Updated: 3:48 PM EDT, Jun 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Erytech Pharma ADR

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Vaxart (NASDAQ:VXRT) shares incr... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million.... 
Via Benzinga
Earnings Scheduled For September 20, 2021
Companies Reporting Before The Bell • Cognyte Software (NASDAQ:CGNT) is expected to report quarterly earnings at $0.15 per share on revenue of $115.57 million. ... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Nuwellis (NASDAQ:NUWE) shares in... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers F-star Therapeutics (NASDAQ:FSTX... 
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 133% to $5.27 after the company announced a $5 million stock repurchase program. Exicure, Inc. (NASDAQ:... 
Via Benzinga
21 Stocks Moving in Monday's Pre-Market Session
Gainers Exicure, Inc. (NASDAQ: XCUR) shares rose 41.5% to $1.91 in pre-market trading. Ipsen and Exicure signed an exclusive collaboration agreement to research, develop, and... 
Via Benzinga
63 Biggest Movers From Friday
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers NanoVibronix (NASDAQ:NAOV) share... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Falls Over 100 Points; Erytech Pharma Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 0.42% to 34,936.96 while the NASDAQ fell 0.75% to 14,667.14. The S&P also fell, dropping 0.53% to 4,395.57. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Erytech Pharma (NASDAQ:ERYP) sha... 
Via Benzinga
Mid-Day Market Update: Atlassian Surges Following Strong Q4 Results; Pinterest Shares Slide
Midway through trading Friday, the Dow traded down 0.25% to 34,996.01 while the NASDAQ fell 0.62% to 14,686.02. The S&P also fell, dropping 0.45% to 4,399.32. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
41 Stocks Moving In Friday's Mid-Day Session
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares jumped 90.6% to $7.84 after the company said the FDA has granted its eryaspase fast track designation for the treatment of acute... 
Via Benzinga
Exposures Product Safety
ERYP Stock: The Huge FDA News That Has Little-Known Erytech Skyrocketing
ERYP stock is seeing a surge in value this morning, as it lands FDA fast track designation for its eryaspase treatment for a second time. 
Via InvestorPlace
Exposures Product Safety
Mid-Morning Market Update: Markets Down; Procter & Gamble Beats Q4 Views
Following the market opening Friday, the Dow traded down 0.10% to 35,049.34 while the NASDAQ fell 0.52% to 14,701.95. The S&P also fell, dropping 0.29% to 4,406.29. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Erytech Pharma's Stock Is Surging Higher Today
Erytech Pharma SA (NASDAQ: ERYP) is surging higher Friday morning after the company announced its eryaspase was granted U.S. FDA Fast Track designation. The Fast... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 79.56% to $7.38 during Friday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
20 Stocks Moving in Friday's Pre-Market Session
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 50.9% to $6.20 in pre-market trading after the company announced its eryaspase was granted U.S. FDA Fast Track designation... 
Via Benzinga
Exposures Product Safety
12 Stocks Moving In Thursday's After-Hours Session
Gainers Atlassian (NASDAQ: TEAM) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued Q1 EPS and sales guidance above... 
Via Benzinga
Why Erytech Pharma Shares Are Soaring Today
Erytech Pharma SA (NASDAQ: ERYP) is surging higher in after hours trading after the company announced its eryaspase was granted U.S. FDA Fast Track designation. The Fast... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Erytech Pharma (NASDAQ:ERYP) sha... 
Via Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
61 Biggest Movers From Yesterday
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 53.01% to $15.47 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume... 
Via Benzinga
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... 
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's morning session saw 27 companies set new 52-week lows. Points of Interest: The company with the largest market cap to set a new 52-week low was... 
Via Benzinga
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.